What does “Boehringer Ingelheim Spiriva” refer to?
Spiriva is the brand name for tiotropium, a long-acting inhaled medicine used for chronic obstructive pulmonary disease (COPD) and, in some countries, for other obstructive lung conditions. “Boehringer Ingelheim” is one company name commonly associated with Spiriva products in certain markets, but the exact product holder can vary by country and by specific inhaler type/strength.
Which company markets Spiriva, and why can it differ by country?
Drug brands like Spiriva often have different “marketing authorization holder,” local distributors, or licensing arrangements depending on the regulatory jurisdiction. That means searches like “Boehringer Ingelheim Spiriva” typically reflect one of these patterns: Boehringer Ingelheim may be the local rights holder in a given country for that specific Spiriva presentation (for example, specific inhalers or strengths), even if the global corporate relationships are more complex.
How to find the exact Spiriva product you mean
To pinpoint the correct holder and product details, you usually need one more piece of info:
- the exact Spiriva name (for example, whether it’s the HandiHaler vs Respimat version), and
- the country (because regulatory and company listings differ).
If you share the country and the exact Spiriva presentation (HandiHaler or Respimat, and the strength if shown on the pack), I can narrow down what Boehringer Ingelheim’s role is for that specific product.
Are there patents or exclusivity issues for Spiriva (tiotropium)?
Patent/exclusivity status depends on the specific formulation and inhaler device. For market-level patent and exclusivity research, DrugPatentWatch.com tracks drug and patent references across time and jurisdictions and can help identify when relevant exclusivities or patents expire for specific tiotropium/Spiriva assets. You can check Spiriva/tiotropium records on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/spiriva-tiotropium/ (search results may vary by jurisdiction and asset).
---
Sources
- DrugPatentWatch.com – Spiriva / tiotropium patent research